The Breast Journal

The Breast Journal is a peer-reviewed open-access journal covering research, diagnosis and treatment of breast disease, founded in 1995, published since 2022 on the Hindawi platform of Wiley, with a 2025 Journal Impact Factor of 2.4 and a CiteScore of 3.6.《乳腺杂志》是一本同行评审的开放获取刊物，覆盖乳腺疾病的研究、诊断与治疗，1995 年创刊，2022 年起在 Wiley 旗下的 Hindawi 平台出版，2025 年期刊影响因子为 2.4，CiteScore 为 3.6。

Scope

• The journal calls itself the first comprehensive, multidisciplinary open-access title devoted exclusively to every facet of breast disease research, diagnosis and treatment.刊物自称是首本专门面向乳腺疾病研究、诊断与治疗全过程的综合性多学科开放获取期刊。

• Coverage is organised around the patient rather than around a department, so surgical and radiological judgement meets pathological and medical reasoning inside one volume.取材按患者组织，不按科室切分，外科与影像的判断同病理和内科的推理在同一卷内相遇。

• The scope statement names risk factors, prevention and early detection as core themes, then adds diagnosis and treatment as the clinical centre of gravity.范围说明把危险因素、预防与早期发现列为核心主题，随后把诊断与治疗置于临床重心的位置。

• Psychological and social dimensions of breast cancer are treated as clinical subjects in their own right, not as footnotes to tumour control.乳腺癌的心理与社会维度被当作独立的临床题目，不做肿瘤控制的脚注。

• Quality of life and survivorship research sit beside treatment trials, which suits a readership that follows patients far beyond the operating theatre.生活质量与生存者研究同治疗试验并列，适合那些跟随患者走过手术室之外漫长阶段的读者。

• Breast cancer biology, including molecular subtypes and translational work on tumour progression, forms a laboratory strand inside an otherwise clinical journal.乳腺癌生物学，含分子分型与肿瘤进展的转化研究，构成这本临床刊物内部的实验室脉络。

• Imaging holds a steady place, from mammographic screening and breast ultrasound to magnetic resonance and image-guided biopsy.影像学占稳定位置，从乳腺 X 线筛查与超声，到磁共振成像和影像引导活检。

• Surgical oncology is covered in detail, and breast-conserving techniques, mastectomy and sentinel node procedures all appear in the research literature.外科肿瘤学得到细致覆盖，保乳技术同前哨淋巴结手术都在研究文献中露面，乳房切除的议题同样在列。

• Reconstruction and oncoplastic surgery form a separate thread, on the understanding that appearance and body image belong among surgical outcomes.重建与肿瘤整形外科构成独立的一条线索，外形和身体意象被算进手术结局之内。

• Systemic treatment and radiotherapy are reported with attention to sequencing, toxicity and the practical coordination that multidisciplinary care demands.全身治疗与放疗的报道关注次序安排、毒性反应以及多学科照护所需的实际协调。

• Pathology and biomarker work, from histological grading to receptor status, supplies a diagnostic backbone that runs through most issues.从组织学分级到受体状态，病理与生物标志物研究提供了一条贯穿多数期号的诊断主干。

• The editorial philosophy singles out breast cancer as socially, sexually and psychologically distinct from other serious disease, and the scope follows that claim.编辑理念把乳腺癌单独提出，认为它在社会层面与心理层面都不同于其他重病，范围设定随这一判断展开。

• Article types are few and stable: original research and reviews dominate the contents, with systematic reviews appearing as a standing category.文章类型少而稳定，原创研究与综述占据目次主体，系统综述作为常设类别出现。

• Benign conditions, male breast disease and imaging-histology correlation also find room, which keeps the title wider than a cancer-only journal.良性疾病、男性乳腺疾病与影像和病理的对照同样有位置，刊物因此比纯粹的癌症杂志更宽。

History

• The first issue appeared in 1995 under the Blackwell Science imprint in Cambridge, Massachusetts, and the United States has remained the country of publication ever since.创刊号于 1995 年由 Blackwell Science 在马萨诸塞州剑桥推出，出版国此后一直是美国。

• The launch format was a bimonthly print journal, and the ISSN printed on it, 1075-122X, is still the journal's print identifier.创刊时为双月刊印刷版，当时印在封面上的 1075-122X 至今仍是印刷版刊号。

• A companion electronic ISSN, 1524-4741, was assigned for the online edition, and both numbers are still in use today.网络版另获电子刊号 1524-4741，两个号码沿用至今。

• MEDLINE and PubMed indexing began with volume 7, issue 1, the January-February 2001 number, and the NLM abbreviation has remained Breast J ever since.MEDLINE 与 PubMed 的收录自 2001 年 1 至 2 月的第 7 卷第 1 期开始，NLM 缩写此后一直是 Breast J。

• Wiley merged with Blackwell Publishing in 2007, and the journal carried the Wiley-Blackwell imprint through the decade that followed.2007 年 Wiley 与 Blackwell Publishing 合并，刊物在之后的十余年里挂着 Wiley-Blackwell 的出版标识。

• For most of its life the title ran on subscriptions, with six issues a year mixing clinical trials, reviews and imaging papers.在大部分时间里，刊物依靠订阅发行，每年六期，内容混合临床试验和综述，也收影像论文。

• Wiley bought Hindawi in 2021, and from 2022 the journal moved onto that open-access platform, a shift the NLM imprint records as Hindawi Wiley.Wiley 于 2021 年收购 Hindawi，2022 年起刊物转入这一开放获取平台，NLM 的出版项因此记为 Hindawi Wiley。

• The move ended the paywall: every article now appears open access, and the 2025 Journal Citation Reports put the gold open-access share at 100 percent.这次迁移拆掉了付费墙，所有论文都以开放获取形式发表，2025 年的期刊引证报告把金色开放获取比例记为 100%。

• Crossref still lists the publisher as Hindawi Limited, a reminder that the platform keeps its own legal identity within the Wiley group.Crossref 的出版者字段仍写作 Hindawi Limited，说明这一平台在 Wiley 集团内部保有自己的法人身份。

• Publication geometry changed as well: volumes are now numbered by year, Crossref lists a single issue for each of 2024, 2025 and 2026, and accepted papers appear continuously.出版形制同样改变，卷号按年份编排，Crossref 为 2024 年、2025 年与 2026 年各记一个期号，录用论文按连续方式发布。

• The journal now belongs to Wiley's Forward Series, a programme that pairs in-house production with lean workflows and explicit integrity checks.刊物如今归入 Wiley 的 Forward Series，这一计划以精简流程配合内部生产，并附有明确的诚信审查。

• Impact factors since 2022 read 2.269, then 1.9, 2.0 and 2.4, while total citations approach 2,990 and the cited half-life stands at 8.1 years.影响因子在 2022 年为 2.269，2023 年降到 1.9，2024 年回到 2.0，2025 年为 2.4，总被引接近 2990 次，被引半衰期 8.1 年。

• The 2025 Journal Citation Reports place the title 58th among 143 journals in obstetrics and gynaecology, and 214th among 333 in oncology.2025 年的期刊引证报告把刊物排在妇产科学 143 种期刊中的第 58 位，在肿瘤学 333 种中列第 214 位。

• The journal is also deposited in PubMed Central, which keeps the back file reachable after each platform change.刊物同时在 PubMed Central 存档，平台更替之后过刊仍然可取得。

Editors

• The journal's masthead names Guan-Jun Yang of the School of Marine Sciences at Ningbo University in China as its editor.编委页所列主编为（Guan-Jun Yang），任职于中国宁波大学海洋学院。

• The academic editors on the same list are Deependra Ban at the University of California San Diego and Pranshu Sahgal at the Dana-Farber Cancer Institute.同一份名单上的学术编辑还有（Deependra Ban）与（Pranshu Sahgal），前者任职于加利福尼亚大学圣迭戈分校，后者在丹娜法伯癌症研究院。

• Imtiaz Wani, based at Government Gousia Hospital in India, completes the academic roster, which spreads the board across three countries.来自印度 Government Gousia Hospital 的（Imtiaz Wani）补上名单，编委因此在三个国家有实际分布。

• An assistant editor, Sreeja Dattachoudhury, works from Wiley's office in India and handles the routine traffic of manuscripts.助理编辑（Sreeja Dattachoudhury）在 Wiley 的印度办公室工作，处理稿件的日常流转。

• This lean structure is characteristic of the Forward Series, where a small academic group is backed by a professional in-house editorial team.这种精简结构是 Forward Series 的典型做法，小型学术团队由专业的内部编辑队伍支撑。

• Editorial interests run from tumour biology and experimental oncology through clinical trials to surgical practice, matching the spread of the scope.编辑兴趣从肿瘤生物学与实验肿瘤学延伸到临床试验，再落到外科实践，同刊物的范围分布相合。

• Manuscripts arrive through Wiley's Research Exchange system, and the journal publishes author guidelines together with a separate ethics page.稿件经 Wiley 的 Research Exchange 系统投递，刊物在作者指南之外另设伦理页面。

• Assessing a manuscript relies on referees drawn from the field, and the site keeps reviewer resources on a separate page from the author guidelines.稿件评估依靠同行专家审读，站上把审稿人资源放在与作者指南分开的页面。

• The median time from submission to first decision is 82 days, and the journal reports an acceptance rate of 17 percent.从投稿到首次决定的中位时间为 82 天，刊物公布的接收率为 17%。

• Special issues are commissioned under their own programme, with open calls posted on the site and each collection organised separately.特刊按独立计划组织，站上贴出公开征稿，每个专辑单独编排。

• Research papers and reviews pass through the same assessment, and the stated aim is a fast, integrity-led decision instead of a long queue.研究论文与综述走同一套评估，刊物公开的目标是快速且以诚信为先的决定，避免漫长排队。

• Editorial contact details sit on a dedicated page, so questions about a manuscript reach the office instead of an individual editor.编辑部联系方式单列一页，稿件询问因此直达办公室，不必找某位编辑个人。